Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) gapped down prior to trading on Wednesday. The stock had previously closed at $12.27, but opened at $11.80. Bavarian Nordic shares last traded at $11.80, with a volume of 142 shares.
Bavarian Nordic Stock Up 0.1%
The business’s 50-day moving average price is $11.48 and its 200 day moving average price is $10.21. The company has a market capitalization of $2.81 billion, a P/E ratio of 11.91 and a beta of 1.33.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last posted its earnings results on Friday, November 13th. The company reported $0.28 earnings per share for the quarter. Bavarian Nordic had a net margin of 24.36% and a return on equity of 11.97%.
About Bavarian Nordic
Bavarian Nordic is a Danish biotechnology company that develops, manufactures and markets vaccines for infectious diseases and cancer immunotherapy. Founded in 1994, the company is based in Denmark and serves markets in Europe, North America and other regions. Its best-known vaccine is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, for protection against smallpox and mpox. Bavarian Nordic also offers vaccines for diseases including rabies, tick-borne encephalitis, typhoid fever and cholera.
Further Reading
- Five stocks we like better than Bavarian Nordic
- These 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
